Category:
Active Pharmaceutical Ingredients
CAS NO:
154229-18-2
Standard:
USP,
Brandon@shenzhoupharma.com
Abiraterone Acetate is a potent CYP17A1 inhibitor synthesized via multi-step organic catalysis. It serves as a key intermediate for androgen deprivation therapy in prostate cancer management.
Strictly store below -20°C under inert atmosphere to prevent hydrolysis. Handling requires full PPE due to potential reproductive toxicity; administration must be co-administered with prednisone to mitigate mineralocorticoid excess.